Microsoft Corporation (MSFT)
Verdict history · MSFT
Every call Verdix has made on MSFT.
While a verdict holds, its return keeps accumulating from the day the call was made — it resets only when the verdict itself changes.
Click any date below to read that write-up
Last month the panel sat at WAIT because the bull case depended on a pullback to $425–$440 or a technical breakout above $505.45 — neither fired. Since then, price eased from $495.40 to $483.24 and the earnings story strengthened sharply (Azure at 43%, Copilot subs doubling, a 12.6% beat), pulling two cautious analysts off the sidelines into BUY. The single Neutral vote today is a pure valuation call, not a business-quality objection, which is why the panel tilts BUY despite conviction staying low.
See methodology for how verdicts are produced. Full track record →
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Software & Cloud (Azure / AI) · 2026-06-29 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on Microsoft after a 33% drop: a wide-moat compounder with Azure growing 40%, now at five-year-low multiples, versus a broken chart and free cash flow gutted by the AI capex cycle. The value frameworks call it cheap; the tape says wait. The debate and the key levels.Level to watch
Key support 357−3.9% from 371.3
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 371.30 (as of 2026-06-29)
This is the panel's clearest "best value, worst tape" standoff — and, unusually, no one argues the business is broken. Microsoft fell ~33% from its ~$555 peak, but Azure reaccelerated to 40% growth, AI annual revenue hit a ~$37B run rate (up ~123%), ROE is ~34%, and the moat — Windows, Office, Azure switching costs plus Copilot upsell — is widening, not narrowing. The decline is almost entirely multiple compression (from ~35x to ~20x), not deterioration. The value and quality frameworks see that as opportunity: fair-value estimates run from $420 to $565, well above the price, and the GARP lens calls a sub-1.0 PEG "the market giving it away." The caution is about the chart and the cash: the stock sits ~18% below its long-term trend in a confirmed downtrend, and a sharply higher AI capex cycle cut free cash flow ~22% year-over-year, with ~45% of the contracted backlog tied to a single customer (OpenAI). The bulls say buy the de-rated quality now; the cautious say world-class business, wrong tape — wait for it to base. That split synthesizes to WAIT.
Key levels
Key levels · MSFT
USD · as of 2026-06-29Analyst consensus target 565 USD · range 460–650
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$392 (the 50-week trend), then the ~$432 breakdown zone, up to the ~$477 level where the long-term trend signal flipped negative. Key support sits at ~$357 (the 2024 base and ~61.8% retracement), then ~$322, with a deeper historical accumulation zone near $287 (the 200-week trend). The analyst consensus target spans roughly USD 460 to 650, averaging near USD 565 — every Street target sits well above the current price, an unusually wide gap that reflects how much the analyst community reads the selloff as multiple compression rather than a broken thesis.
What legendary investors think
We ran Microsoft past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🟢 BullishHigh
"The moat is as wide as ever, and widening" — Azure +40%, AI at a $37B run rate, ROE ~34%, debt/equity ~0.30. At ~22x the margin of safety has "meaningfully improved from the 30x+ we saw earlier"; the one concern is the capex compressing gross margin to ~67.6%, the narrowest since 2022.
The GARP OperatorGrowth (GARP)🟢 BullishMed-High
"The 33% drop did the work the market usually refuses to do" — a trailing PEG near 0.73 on ~30% EPS growth, a stalwart growing like a fast grower but priced like an ordinary business. "The story did not break, only the price did."
The Intrinsic-Value ModelerValuation🟢 BullishMedium
A DCF lands near $420 (+13%): the drawdown "moved MSFT from overvalued to modestly undervalued," now pricing a plausible-not-heroic ~16% growth path. The margin of safety that didn't exist at $555 exists at $371 — though he'd want free cash flow to stabilize before sizing aggressively.
The Forensic SkepticContrarian⚫ NeutralMedium
"The business is fine. The price is not distressed." The 33% fall is multiple compression (38–40x → ~30x on his normalized basis), not deterioration; intrinsic ~$340–380 leaves no margin of safety yet, and OpenAI is ~45% of the $627B backlog — a real concentration risk. (Notably building a long-dated position around $350.)
The Disruptive-Innovation SeekerGrowth⚫ NeutralMedium
Azure AI is real and accelerating (run rate +123%), but Copilot is only ~4.4% penetrated and the ~$190B capex plus 27% OpenAI stake are double-edged. At a ~$2.8T cap it's "priced for competent execution, not exponential surprise" — would add aggressively toward $300.
The Macro OpportunistMacro🔴 BearishLow
"World-class business, wrong tape, wrong liquidity backdrop." The stock is ~18% below its 200-day in its worst month since the dot-com era, with the Fed higher-for-longer; "I don't catch falling knives." The burden is on the bulls to reclaim ~$449 before he's interested.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The fundamentals are strong and improving: Azure reaccelerated to 40%, AI revenue is at a ~$37B run rate (+123%), operating margin ~45%, ROE ~34% — among the best numbers Microsoft has reported.
- The 33% drop is a re-rating, not a breakdown: every framework, including the bears, attributes it to AI-capex multiple compression rather than business deterioration.
- The capex cycle is the real cost: a sharply higher AI build cut free cash flow ~22% year-over-year, and the depreciation ramp hasn't fully hit the income statement.
- OpenAI is both anchor and risk: ~45% of the contracted backlog, a customer now diversifying its cloud providers.
The real debate
- Cheap or just less expensive? The value and quality lenses see five-year-low multiples on a 40%-Azure compounder as a gift; the Forensic Skeptic sees a fairly-priced great business with no margin of safety until the $340s.
- Buy the de-rating or wait for the tape? The fundamental case says the price already discounts a prolonged FCF depression the data doesn't support; the macro and technical lenses say a confirmed downtrend below the 200-week trend is not to be caught.
- Does the capex pay back? Bulls frame ~$80B+ of capex as essential platform-shift investment; the skeptics note FCF stays suppressed for years before the AI revenue fully scales.
The question it comes down to: Is Microsoft a wide-moat compounder that the AI-capex scare has handed back at five-year-low multiples — or a still-richly-capitalized business whose free cash flow stays gutted long enough, and whose OpenAI dependence runs deep enough, that the broken tape is telling the truth?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 371.30 / ~2.77T |
| P/E (TTM / fwd) | ~22x / ~19x (vs ~30–35x at the peak) |
| ROE | ~34% |
| Operating margin | ~45% |
| Dividend yield | ~0.9% |
| Debt / equity | ~0.30x (net cash) |
| Free cash flow | ~USD 15.8B (Q3 FY2026, down ~22% YoY on the AI capex ramp) |
Figures as of Q3 FY2026 (quarter ended March 2026) / June 2026; sourced from Microsoft IR/SEC filings, StockAnalysis, GuruFocus, MacroTrends, MarketBeat. Full-year AI capex figures vary by source (quarterly capex in the low-$30Bs; full-year estimates cited from ~$80B toward higher multi-year commitments); the consistent fact is a sharply higher build that cut free cash flow ~22% YoY. Forward multiples reflect consensus EPS; a normalized-earnings view (accounting for the depreciation ramp) yields a higher effective multiple.
The bottom line
Microsoft is the rare large-cap where almost every framework likes the business and several like the price — and the verdict still lands on patience, because the chart and the cash flow disagree with the value case for now. The bull argument is grounded and, on the latest quarter, accelerating: Azure reaccelerated to 40%, AI revenue compounds past a $37B run rate, the moat is widening through Copilot upsell across 300M+ commercial seats, ROE is ~34%, and the 33% drawdown compressed the multiple from the mid-30s to roughly 20x — handing the quality and value lenses fair-value estimates from $420 to $565, all above the price. The caution is equally concrete and, this quarter, dominant in the tape: the stock sits ~18% below its long-term trend in its worst month in a generation, a sharply higher AI capex cycle cut free cash flow ~22% with the depreciation ramp still building, and ~45% of the backlog leans on an OpenAI relationship that is diversifying away. What would tip the synthesis decisively bullish is the tape repairing — a reclaim of the long-term trend on volume — alongside free cash flow stabilizing as the capex cycle peaks, which would confirm the value frameworks are right that this is cheap rather than merely cheaper. What keeps it a wait is that, until the downtrend bases and the cash flow turns, the panel is being asked to catch a world-class business mid-fall — and the bulls who'd buy it here are outweighed, for now, by the voices saying the same company will be available with the tape on their side.
contact@verdixhq.com · Published 2026-06-29 · Prices as of 2026-06-29 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s split verdict on MSFT — and where they disagree.
The case for and against roughly balance — no clear edge at today's price.
NASDAQ · Technology / Software & Cloud · 2026-07-11 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BalancedMEDIUM confidence
Why
Six investing legends on Microsoft after a ~19% slide from its highs: a wonderful cloud-and-AI compounder — Azure +40%, AI at a $37B run-rate — now trading below its own historical multiple, but with a broken weekly chart and free cash flow squeezed by record AI capex. The value lenses want to own it; the tape and the forensic lens say wait. The debate and the key levels.Level to watch
Key support 360−6.5% from 385.1
The panel's take
Verdict: BALANCED · Conviction: MEDIUM · Last price: USD 385.10 (as of 2026-07-11)
Microsoft is the panel's cleanest "own the quality, don't chase the tape" call. Nobody disputes the business: Azure reaccelerated to ~40% growth in Q3 FY2026, the AI business is at a ~$37B annualized run-rate (+123% YoY), commercial backlog sits at ~$627B, and the whole engine throws off ~30% ROE on minimal leverage. On the numbers it has actually gotten cheaper — ~23x trailing and ~20x forward, roughly a quarter below its own trailing-twelve-month average multiple — which is why the value, GARP, and innovation lenses all lean bullish and the analyst consensus target sits far above the price. But the split is real and it is about timing, not quality: the weekly chart is broken (down ~19% YTD, trading below a ~$440 200-day, lower highs and lower lows since the ~$555 top), and free cash flow fell despite record operating cash flow as AI capex climbed above $40B a quarter — a monetization bet the forensic and macro lenses refuse to underwrite until it shows up in cash. With three lenses saying "wonderful business, add on weakness," three saying "fair value, unconfirmed tape, prove the capex pays," and a Q4 FY2026 print landing July 29, the synthesis is BALANCED.
Key levels
Key levels · MSFT
USD · as of 2026-07-11Analyst consensus target 575 USD · range 400–680
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance starts at ~$440 (broken 2025 support, now overhead supply near the falling Supertrend), then the ~$480 consolidation ceiling, up to the ~$555 all-time-high supply zone. Key support sits at ~$360 (the recent weekly swing low), then the ~$320 2024 breakout base, with a deeper historical accumulation zone near ~$280. The analyst consensus target spans roughly USD 400 to 680, averaging near USD 575 — well above the current price, an unusually wide Street-versus-tape gap that reflects the same debate the panel is having: cheap quality on fundamentals, unconfirmed on the chart.
What legendary investors think
We ran Microsoft past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue🟢 BullishHigh
"About as wide a moat as any business I know" — enterprise switching costs plus the Office/Azure network effect, throwing off ~30% ROE and ~27% ROIC on little leverage. At ~23x trailing, below its own ~31x average, "you're not overpaying for the quality — this is a compounder I'm happy to hold forever and would add aggressively on any real pullback." Not a fat-pitch margin of safety, but a wonderful business at a fair price.
The GARP OperatorGrowth (GARP)🟢 BullishMedium
A stalwart with a fast-grower engine inside it. Forward P/E ~20x against realistic 13-15% EPS growth puts PEG near ~1.3 — "fair, not a bargain, but not overvalued." Azure at 40% and AI at a $37B run-rate are "fast-grower economics bolted onto a stalwart's balance sheet." A sleep-at-night compounder, not a ten-bagger from here.
The Disruptive-Innovation SeekerGrowth🟢 BullishHigh
Microsoft is "the picks-and-shovels layer of the AI platform shift." Azure reaccelerating to 40% and Copilot crossing 20M paid seats say enterprise AI is still early on its S-curve. Reads cloud gross-margin compression (to ~66%) as Wright's-Law capex that compounds into efficiency later — traditional margins understate the trajectory. Five-year view materially higher.
The Intrinsic-Value ModelerValuation⚫ NeutralMedium
A story-to-numbers DCF (14% revenue growth fading to 8%, margins nudging to ~46-47%, ~9% WACC) lands fair value around $360-400 — roughly in line with today, "maybe slightly rich." The market is pricing continued margin expansion despite capex intensity, "a narrow needle to thread." Wants confirmation of capex discipline before calling it undervalued.
The Forensic SkepticContrarian⚫ NeutralMedium
Not a franchise short — a cash-flow flag. Q3 FCF fell ~22% YoY to ~$16B despite record operating cash flow, with Q4 capex guided above $40B against a ~$190B FY plan. "The ~20x multiple is cheap only if AI capex converts to durable margin — unproven." The tail risk everyone waves away in the "cheap" framing is capex outrunning monetizable demand.
The Macro OpportunistMacro⚫ NeutralLow
"Fundamentals are excellent; the price action isn't confirming them." Down ~19% YTD and below its ~$440 200-day while the Nasdaq just had its best month since 2020 — that's lost relative strength, a broken trend, not a pullback in an uptrend. With the Fed on hold, "I don't fight tape like this." Would flip bullish on a reclaim of the 200-day on volume or a clean Q4 print.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business quality is not in question: Azure ~40%, AI ~$37B run-rate (+123% YoY), ~$627B backlog, ~30% ROE, low leverage — one of the widest moats in the market.
- The valuation has de-rated: ~23x trailing / ~20x forward, roughly a quarter below its own trailing-average multiple, with the analyst consensus target far above the price.
- The swing factor is AI capex: >$40B a quarter is compressing free cash flow even as operating income grows.
- The near-term tape is broken: below the 200-day, down ~19% YTD, lower highs and lower lows since the ~$555 top.
The real debate
- Cheap quality or value trap in slow motion? The value/GARP/innovation lenses say a wonderful business below its own average multiple is a gift; the macro lens won't buy a stock losing relative strength to its own sector.
- Does the capex pay? The innovation lens frames capex as Wright's-Law investment that compounds into margin; the forensic lens frames it as a depreciation bet where FCF conversion already doesn't support the multiple.
- Fair or slightly rich? The DCF lands right around today's price, so this becomes a margin-durability question, not a growth question.
The question it comes down to: Is Microsoft a rare chance to own the widest moat in software below its own historical multiple while the tape is temporarily broken — or a fairly-priced compounder whose record AI capex has to start converting to cash before the chart and the bulls are proven right?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 385.10 / ~2.87T |
| P/E (TTM / fwd) | ~23x / ~20x (vs ~31x trailing-average) |
| Q3 FY2026 revenue / EPS | USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY) |
| ROE / operating margin | ~30% / ~45% |
| Azure / AI | Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$627B |
| Dividend yield | ~0.9% (20 consecutive annual increases) |
| Balance sheet | Debt/equity ~0.2; FY2025 FCF ~$71.6B (-3% YoY as capex ramps; Q3 capex ~$31.9B, Q4 guided >$40B) |
Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 11, 2026; sourced from Microsoft IR, CNBC, GuruFocus, MacroTrends, StockAnalysis, TIKR, Alphastreet. Azure 40% growth and the $560-590 avg) sits well above the price; Stifel's ~$400 is the low. Next print: July 29, 2026 (Q4 FY2026, after close).$37B AI run-rate are the reliable growth signals; the swing factor is capex intensity ($190B FY plan) compressing near-term FCF conversion. Analyst consensus (
The bottom line
Microsoft is the panel's most straightforward BALANCED verdict — a genuinely wonderful business whose price has fallen far enough to interest the value lenses, held back by a broken chart and an unresolved question about whether its AI capex converts to cash. The bull case is real and cheap by Microsoft's own standards: Azure back to ~40%, AI at a ~$37B run-rate, a ~$627B backlog, ~30% ROE, and a multiple roughly a quarter below its trailing average, which is why three independent lenses lean bullish and the Street consensus sits near $575. But the caution is equally concrete: free cash flow fell even as operating cash flow hit records because capex now runs above $40B a quarter, the stock is below its 200-day and down ~19% YTD while its own sector rallies, and the intrinsic-value work lands right around today's price rather than below it. What would tip the call decisively bullish is confirmation on both fronts — a clean Q4 FY2026 print on July 29 showing Azure durability and capex beginning to convert to free cash flow, plus a reclaim of the ~$440 200-day on volume. What keeps it BALANCED is that, until then, buyers are paying a fair price for a broken chart on the promise that the biggest capex cycle in the company's history pays off — the same wonderful business will be far easier to own once the cash flow and the tape confirm it.
contact@verdixhq.com · Published 2026-07-11 · Prices as of 2026-07-11 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Technology / Software & Cloud · 2026-07-18 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six investing legends on Microsoft after a failed test of $440-465 resistance: the business case — Azure +40%, a $627B backlog, 30% ROE — is unanimous, but five of six lenses want the July 29 earnings print to confirm AI capex is converting to free cash flow before paying up. Only one lens is buying now. The debate and the key levels.Level to watch
Key support 360−8.6% from 393.82
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 393.82 (as of 2026-07-18) · Changed from BALANCED
What changed since 2026-07-11:
- Price: USD 385.10 → 393.82 (+2.3%) — a rally pushed into the $440 resistance shelf and printed as high as $465 before being rejected back down to retest $360 support, which held before the stock bounced.
- Panel: 3 of 6 → 1 of 6 now Bullish (The Moat Compounder and The GARP Operator moved to Neutral from Bullish) — the business case is now unanimous, but five of six lenses want the July 29 print to confirm AI capex is converting to free cash flow before adding conviction.
- Trigger: The July 29 Q4 FY2026 print; until then the panel is watching for a close-and-hold above $440 on volume.
- Verdict: BALANCED → WAIT
Every lens now agrees on the business — Azure at 40% growth, a $37B AI run-rate, and a $627B backlog make this one of the best businesses in the market — so the debate has narrowed entirely to timing. Five of six lenses read this week's failed test as unfinished business, not a broken thesis, and want confirmation — a clean print plus a reclaim of $440 — before adding capital. Only the disruptive-innovation lens is buying now, arguing the Supertrend flip off $360 already signals the market pricing the AI S-curve ahead of confirmation. With the business unanimous and the disagreement centered entirely on timing a known catalyst just eleven days out, the panel's synthesis moves from BALANCED to WAIT.
Key levels
Key levels · MSFT
USD · as of 2026-07-18Analyst consensus target 575 USD · range 400–680
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key resistance sits at ~$440 (the level this week's rally reached toward, peaking near $465 intraweek before closing back below it), then ~$480, up to the ~$555 all-time-high supply zone. Key support held again at ~$360 (a shelf tested and defended for a second time), then the ~$320 2024 breakout base, with a deeper historical accumulation zone near ~$280. The analyst consensus target spans roughly USD 400 to 680, averaging near USD 575 — a wide gap above the current price that mirrors the panel's own split: cheap on the fundamentals, not yet confirmed on the tape.
What legendary investors think
We ran Microsoft past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMedium
"A fine company at a fair price, not a fair price with the wind at its back." A ~30% ROE machine at ~23.5x earnings against a ~31x historical average is attractive, but the tape's failed $440 reclaim and retreat to $360 means the weighing machine hasn't agreed with the business yet — watching the July 29 print for capex-to-FCF confirmation and a real close above $440.
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
Azure at 40%, AI run-rate at $37B (+123%), and a 30% ROE at a PEG-friendly discount to the ~31x historical multiple is "exactly the kind of setup that gets my attention" — but the stock got rejected at $465 and held $360 almost to the print, "a stock still finding itself, not one that's broken out." Waiting on the Q4 earnings and the capex-to-FCF test 11 days out.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
Reads the Supertrend flip off the defended $355-360 zone as the market beginning to price the AI S-curve inflection ahead of confirmation, with the 46% gap to the $575 consensus target unjustified by multiple compression alone. Treats the failed $440-465 test as digestion of record AI capex, not a broken thesis — five-year lens looks through the July 29 print noise.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMedium
"Price is the market's current opinion, value is what the cash flows justify" — a ~30% ROE, ~45%-margin compounder below both its own ~31x multiple and the $575 Street target is interesting, but this week's rejection at ~$465 against the defended $360 support is "a standoff, not a resolution." Wants the July 29 print to distinguish "cheap compounder" from "capex-funded growth story the market is right to discount."
The Forensic SkepticContrarian/Forensic⚫ NeutralMedium
The footnote: FY2025 free cash flow actually fell 3% to $71.6B while quarterly capex is now guided above $40B, so a $37B AI run-rate and $627B backlog "mean nothing until they show up as free cash flow." The rally to $465 was rejected exactly where the tape needed to close and hold — "not a reclaim, a failed test" — and the 46% gap to consensus "isn't a margin of safety, it's a market waiting on July 29 the same way I am."
The Macro OpportunistMacro/Timing⚫ NeutralMedium
"I never confuse a great company with a great stock at the wrong moment." The move to ~$465 pierced $440 intraweek but closed back below it — sellers still control that level — while $360 held and Supertrend flipped bullish, so not bearish either. Wants a close-above-$440-on-volume signal before getting aggressive, with capex above $40B/quarter squeezing FCF into an unconfirmed July 29 print.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- The business quality is not in question: Azure +40%, AI run-rate ~$37B (+123% YoY), ~$627B backlog, ~30% ROE, ~45% operating margin — no lens disputes the fundamentals this week.
- Valuation looks cheap by Microsoft's own history: ~23.5x trailing versus a ~31x historical average, with the analyst consensus target ~46% above the current price.
- The tape delivered a clean, shared data point: a failed test of the $440-465 resistance shelf, rejected back down, followed by a successful second defense of ~$360 support.
- The swing factor everyone names is the same: whether AI capex above $40B a quarter starts converting to free cash flow, testable at the July 29 Q4 FY2026 print.
The real debate
- Buy the S-curve now, or wait for the print? The disruptive-innovation lens reads the Supertrend flip off $360 as the market already starting to price the AI inflection; the other five want the July 29 report to actually confirm capex is converting to cash before committing new capital.
- Is "cheap" already proven, or still a promise? The value, GARP, and intrinsic-value lenses see a quality compounder trading below its own multiple; the forensic lens counters that FY2025 free cash flow fell 3% even as the AI run-rate and backlog headlines grew, so the "cheap" framing isn't yet backed by cash.
- Does the chart need to lead, or can it follow? The macro lens treats a close-and-hold above $440 on volume as the precondition for getting aggressive; the innovation lens is comfortable buying ahead of that confirmation.
The question it comes down to: Does Microsoft's business quality already justify buying ahead of confirmation — or does the market need the July 29 print, and a real close above $440, to prove that record AI capex is converting into free cash flow rather than just compressing it?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 393.82 / ~2.94T |
| P/E (TTM / fwd) | ~23.5x / ~20x (vs ~31x trailing-average) |
| Q3 FY2026 revenue / EPS | USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY) |
| ROE / operating margin | ~30% / ~45% |
| Azure / AI | Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$627B |
| Dividend yield | ~0.9% (20 consecutive annual increases) |
| Balance sheet | Debt/equity ~0.2; FY2025 FCF ~$71.6B (-3% YoY as capex ramps; Q3 capex ~$31.9B, Q4 guided >$40B) |
Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 18, 2026; sourced from Microsoft IR, CNBC, GuruFocus, MacroTrends, StockAnalysis, TIKR, Alphastreet. Azure 40% growth and the $560-590 avg) sits well above the price; Stifel's ~$400 is the low. Next print: July 29, 2026 (Q4 FY2026, after close).$37B AI run-rate are the reliable growth signals; the swing factor remains capex intensity ($190B FY plan) compressing near-term FCF conversion. Analyst consensus (
The bottom line
A close-and-hold above $440 on real volume would be the first tape confirmation for the five lenses currently on Neutral, independent of the earnings print. The July 29 Q4 FY2026 report is the swing event: free cash flow conversion improving from the FY2025 trend (down 3% to $71.6B despite capex above $40B a quarter) would resolve the forensic lens's core objection and likely pull the value and GARP lenses back toward Bullish. A close below $360 on volume, conversely, would be the first read that turns a business-quality skeptic's argument rather than a timing one — nobody on the panel expects that outcome today. Absent either signal, expect the panel to stay split between one lens already positioned for the AI S-curve and five waiting on the print eleven days out.
contact@verdixhq.com · Published 2026-07-18 · Prices as of 2026-07-18 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Technology / Software & Cloud · 2026-07-25 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Six lenses revisit Microsoft four days from the July 29 print: the business case — Azure +40%, a $627B backlog, ~30% ROE — is still unanimous, and the stock got cheaper, not more expensive, sliding roughly 3% into a fresh double-top at $403-406 while the $355-365 floor held for a second time. Free cash flow fell another notch (down 22% YoY last quarter) against a widening $190-262B capex range, so five of six lenses are still waiting on Thursday's earnings before adding conviction, while one lens keeps reading the AI buildout as an opportunity already being priced. The debate and the key levels.Level to watch
Key resistance 403+5.6% from 381.7
The panel's take
Verdict: WAIT · Conviction: MEDIUM · Last price: USD 381.70 (as of 2026-07-25)
What changed since 2026-07-18:
- Price: USD 393.82 → 381.70 (-3.08%) — the rally that had pushed into $440-465 faded back down, printing two flat weekly closes at 381.70 after a fresh rejection at $403-406. Note: the latest bar is a partial/low-volume week and should be read as provisional, not a confirmed close.
- Panel: composition unchanged — 1 of 6 still Bullish (The Disruptive-Innovation Seeker), 5 of 6 still Neutral, all five still parked on the same catalyst.
- Catalyst: the July 29 Q4 FY2026 print is now four days out (was eleven last week) — and now lands the same day as an FOMC decision, with rate-cut odds fading rather than firming.
- New risk: the nearest resistance moved closer, not farther — a genuine double-top at $403-406 (from the last two completed weekly bars) now sits between spot price and the $440 level the panel was watching, and the bounce into it came on declining volume, a mild distribution tell.
- New offset: a 10-year Databricks partnership extension and an AMD Helios inference deployment inside Azure data centers are margin-supportive signals since last week; separately, April's Microsoft-OpenAI agreement amendment cuts both ways — it de-risks the single-customer concentration (still ~45% of the $625-627B backlog) but opens a path for gradual workload migration off Azure.
- Verdict: WAIT (unchanged).
Nothing resolved this week — it just got four days closer to resolving. The business case stayed unanimous (Azure +40%, a $37B AI run-rate, ~30% ROE), and the stock actually got cheaper on that unchanged case, with the forward multiple compressing further toward ~20x. But the tape didn't reward the cheaper multiple: price faded from $393.82 to the $381-388 range, rejected again at a closer, freshly-confirmed $403-406 zone rather than testing the $440 level the panel had been watching, while Q3 free cash flow's 22% YoY decline against a still-widening $190-262B capex range kept the core objection alive. Five of six lenses hold their ground into a now-imminent catalyst; only the disruptive-innovation view continues to treat the capex ramp itself as the buy signal.
Key levels
Key levels · MSFT
USD · as of 2026-07-25Analyst consensus target 580 USD · range 400–870
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
The level that actually matters right now sits closer than the panel's prior trigger: $403-406 is the real double-top from the last two completed weekly bars, and price needs to clear that before $440 is even relevant again. Above it, $440 and $480 remain untested since April/May, with the 2025-07-28 all-time-high zone near $555 still the ceiling of the range. On the downside, $355-365 has now been defended twice (March and June 2026) and price sits comfortably above it. The deeper support commonly cited near $320 is more precisely the Aug 2023 low (~$311-320) — a level roughly three years untested, plausible as structural support but weaker than a recent-cycle floor. The previously cited $280 level has no supporting print anywhere in the OHLC record and is dropped this week pending deeper historical data. The analyst consensus band ($400 to $870, average near $580) sits well above spot — a gap that widened, not narrowed, since targets mostly held while price fell.
What legendary investors think
We ran Microsoft past a panel of six legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat⚫ NeutralMedium
The moat hasn't moved an inch — Azure at 40%, a $627B backlog, ~30% ROE — but the price drifting toward a one-year low on unchanged fundamentals reads as the market pricing doubt about capex discipline, not doubt about the business. "A fine business marking time while the market waits for a receipt, not a promise — my job is to wait for the receipt too."
The GARP OperatorGrowth (GARP)⚫ NeutralMedium
Forward P/E has compressed to ~20x, the cheapest multiple since 2023, while FY2027 capex chatter has widened to a $220-262B range — "the kind of arithmetic that makes me want to buy the dip, not chase the rally," but a cheap multiple on a story stock only pays off once earnings actually show up. "The person who turns over the most rocks wins the game" — and the rock still to be turned is Thursday's free-cash-flow number.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMedium
Capex guidance firmed rather than softened (calendar-2026 near $195B, Q4 guided above $40B) and the AI run-rate keeps compounding at +123% YoY — record spend today is tomorrow's Azure capacity. "The market wants to see AI capex convert to free cash flow before it believes the story — we'd argue the conversion is already visible in the 123% run-rate growth, the cash flow lag is simply the physical reality of building the picks and shovels first."
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMedium
The gap to the ~$580 average consensus target widened as price slipped, but that's not yet evidence, just a wider question. "Price is the market's current opinion, value is what the cash flows justify" — and until Thursday the cash flows have only shown a deeper near-term drag, not a resolution either way.
The Forensic SkepticContrarian/Forensic⚫ NeutralMedium
Quarterly free cash flow fell 22% YoY to $15.8B against $30.9B of capex — confirmation, not contradiction, of last week's footnote. "A backlog is a promise; free cash flow is a fact, and this week the facts got worse, not better." Calls the drift back toward $360 without a breakdown "genuinely undecided, not mispriced."
The Macro OpportunistMacro/Timing⚫ NeutralMedium
The stock backslid toward $360 instead of confirming above $440, and the July 29 print now collides with an FOMC decision where rate-cut odds have faded toward a possible hold-or-hike tilt. "I never confuse a great company with a great stock at the wrong moment" — wants the tape to lead, and right now it's giving a question mark, not a green light.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Business quality is unchanged and undisputed: Azure +40%, AI run-rate ~$37B (+123% YoY), ~$627B backlog (~45% tied to one customer), ~30% ROE, ~45% operating margin.
- Valuation got more attractive, not less: ~23.9x trailing / ~20x forward against a ~31x historical average, the cheapest multiple since 2023 on the GARP read.
- Everyone read the same tape this week: a fade from $393.82 to the $381-388 range, a fresh rejection at $403-406 replacing $440 as the near-term hurdle, and a second successful defense of the $355-365 shelf.
- The swing event is unchanged and now imminent: the July 29 Q4 FY2026 print, testing whether $190-262B of capex converts to free cash flow after Q3's 22% YoY FCF decline.
The real debate
- Buy the S-curve now, or wait for the print? The disruptive-innovation lens is unmoved — firmer capex guidance reads as conviction, not risk — while the other five still want July 29 to actually show conversion before adding capital.
- Is "cheap" already proven, or still a promise? The GARP and intrinsic-value lenses see the compressed multiple as the math improving; the forensic lens counters that free cash flow fell further this quarter, so "cheap" still isn't backed by cash.
- Does the calendar add a new variable? The macro lens is the only one weighting the same-day FOMC decision explicitly — a hawkish tilt landing alongside a soft print, in that reading, would turn a timing question into a straightforward liquidity-driven de-rate.
The question it comes down to: Does the panel's already-unanimous business case survive four more days of digestion and a same-day Fed decision without new evidence — or does Thursday's print, and a reclaim of the nearer $403-406 zone before $440 is even relevant, need to arrive first before five of six lenses move off Neutral?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 381.70 / ~2.84T |
| P/E (TTM / fwd) | ~23.9x / ~20x (vs ~31x trailing-average) |
| Q3 FY2026 revenue / EPS | USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY) |
| ROE / operating margin | ~30% / ~45% |
| Azure / AI | Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$625-627B (~45% tied to one customer) |
| Dividend yield | ~0.9% (20 consecutive annual increases) |
| Balance sheet | FY2025 FCF ~$71.6B (-3% YoY); Q3 FCF ~$15.8B (-22% YoY) vs Q3 capex ~$30.9B; FY2026 capex guided ~$190-195B, FY2027 chatter spans $220-262B |
Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 25, 2026, with the latest weekly bar noted as partial/provisional; sourced from Microsoft IR, Robinhood, TradingKey, StartupHub, Motley Fool, StockAnalysis, AlphaQuery, 24/7 Wall St. Azure ~40% growth and the $37B AI run-rate remain the reliable growth signals; the swing factor is still capex intensity compressing near-term free cash flow conversion. Analyst consensus ($400-870 range, average ~$580) sits well above spot, a gap wider than the July 18 read since targets mostly held while price fell. Next print: July 29, 2026 (Q4 FY2026, after close), the same day as the July FOMC decision.
The bottom line
The July 29 print, four trading days out, remains the single event that can move five of six lenses off Neutral in either direction. A quarter showing free cash flow stabilizing or improving against the ~$190B FY2026 capex plan — with FY2027 guidance landing nearer the $220B end than the $262B high-end chatter — would resolve the forensic objection directly and likely pull the GARP and intrinsic-value lenses back toward Bullish, especially with the forward multiple already compressed to ~20x. A soft print, or guidance confirming capex is structurally outrunning cash generation, would harden the skeptical case without needing $355-365 to break first — the facts, not the chart, would do the work. Complicating either outcome, Thursday's report now shares a calendar day with an FOMC decision where rate-cut expectations have faded, adding a liquidity variable none of the other five lenses weight explicitly. Until then, with the nearest confirmed resistance now $403-406 rather than $440, and the defended floor at $355-365 still intact, the panel's synthesis holds exactly where it did last week: WAIT.
contact@verdixhq.com · Published 2026-07-25 · Prices as of 2026-07-25 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Technology / Software & Cloud · 2026-08-02 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Microsoft's Q4 FY2026 earnings beat sent the stock up 22% in a week to $464.72, and five of six investor archetypes now call the business bullish outright — but the panel still lands on WAIT: the rally has already priced in most of the good news, and both the technical read and the deep-value lens want a breakout confirmation or a pullback before adding. The debate has shifted from 'is this a good business' (settled, unanimously) to 'has the market already paid for it.'Level to watch
Key resistance 468.35+0.8% from 464.72
The panel's take
Verdict: WAIT · Conviction: MED · Last price: USD 464.72
What changed since 2026-07-25:
- Price: USD 381.70 → 464.72 (+21.8%) — a 22% one-week surge following the July 31 Q4 FY2026 earnings beat: revenue of $90B (+18% YoY, beat the $87.7B consensus), EPS of $4.81 (vs. $4.24 consensus), Azure accelerating to 43% YoY and guided to 45% next quarter, and commercial backlog (RPO) up 99% YoY to $627B.
- Panel: 1 of 6 → 5 of 6 now Bullish — composition also changed: added The Scuttlebutt Growth Investor, The Asymmetric Bargainer; removed The Forensic Skeptic, The Macro Opportunist.
- Trigger: BUY on a weekly close above USD 490 (weekly horizontal resistance), confirming the breakout has real follow-through. WAIT/accumulate on a pullback into the USD 427–435 zone (61.8% Fibonacci retracement, weekly volume point-of-control, and monthly EMA20 all cluster here) — the level both the price-discipline voices and the technical read point to as a historical accumulation zone. SELL on a weekly close below USD 427.33 (invalidating the recovery bounce) OR two consecutive quarters of sub-30% Azure growth OR a sequential decline in the $627B backlog.
- Verdict: WAIT (unchanged)
The business case flipped from contested to nearly unanimous in a single earnings print. A week ago the panel was split on whether the AI capex cycle would convert to durable cash flow; the July 31 report answered that question for five of six voices — Azure's acceleration, the $627B backlog, and a CFO who proactively dismantled the AI-overcapacity bear case on the call moved The Moat Compounder, The GARP Operator, The Scuttlebutt Growth Investor, The Intrinsic-Value Modeler, and The Disruptive-Innovation Seeker all into the bull camp. But the stock did the work for them — a 22% rally in a week means the price-discipline voices, The Asymmetric Bargainer chief among them, now see a fundamentally excellent business trading with no further margin of safety at $465, sitting directly against a monthly resistance level it hasn't yet cleared.
WAIT over BUY because the objection is price and timing, not business quality — nobody on the panel disputes the Azure/AI story anymore. WAIT over HOLD because there is no genuine disagreement about the thesis to sit and monitor; the cautious voices are explicit that they want to own MSFT, just not at a price with the easy money already made. The technical read agrees with that framing on its own terms: price is pressing directly against the nearest monthly resistance ($468.35) while the monthly MACD is still in a confirmed bearish posture even as the weekly momentum turns up — a genuine cross-timeframe conflict, not a clean breakout.
Key levels
Key levels · MSFT
USD · as of 2026-08-02Analyst consensus target 550 USD · range 400–870
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Microsoft Corporation past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: A perfect 15/15 on the qualitative checklist — Azure surpassing $100B in annual revenue, a CFO who candidly dismantled the AI-overcapacity bear case on the call, and a forward P/E of 23.7 below the market multiple for a business accelerating into the AI era. Conviction: Scuttlebutt from customers and competitors, the checklist score, and management's own candor all independently point the same direction — this is a "hold almost never sell" name.
The GARP OperatorGrowth (GARP)🟢 BullishHigh
Signal: The $627B contracted backlog tells me the growth is real — that's signed commitments, not hopeful projections — and at a PEG of 1.5 against 17%+ EPS growth, you're paying a fair price, not a speculative one. Conviction: The backlog, the earnings-call candor, and a fundamentals-over-technicals read all reinforce each other; I've never made money trading MACD lines, and the 21% rally doesn't change what the business is worth over 3–5 years.
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: A durable, widening moat — enterprise switching costs, LinkedIn network effects, the OpenAI partnership — paired with 34% ROE and 40% net margins, at 25.9x earnings against a 5-year average near 30x, is a fair price for an exceptional business. Conviction: Business quality, balance-sheet strength, and management discipline are all independently verified; the only thing holding conviction to Medium rather than High is that the 21% rally already priced in much of the good news.
The Disruptive-Innovation SeekerDisruptive Innovation🟢 BullishMed
Signal: Enterprise AI adoption is still early — Copilot penetration under 5% of addressable seats today — and the $627B backlog de-risks the growth thesis in a way a simple P/E multiple can't capture; a forward 23.7x for an 18%+ revenue CAGR platform is a gift, not a stretch. Conviction: The backlog, the accelerating Azure guide, and management's active narrative management on capex flexibility are three separate confirmations, though the S-curve thesis itself still depends on Copilot monetization actually showing up in the numbers.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: My base-case DCF lands at $483 — only 4% above the current $464.72 — so the market is pricing in a plausible AI story with very little margin of safety left; the $627B backlog is a genuine, high-visibility positive, but the heavy capex is the wildcard that could just as easily produce a $415 bear case. Conviction: Held to Medium because the base and bear cases are close together ($483 vs $415) — the swing factor is whether reinvestment efficiency holds, a single assumption the rally hasn't resolved either way.
The Asymmetric BargainerContrarian/Deep Value⚫ NeutralMed
Signal: This is a wonderful business at a fair price, not a Dhandho bargain — at 24x forward earnings after a 21% weekly rally, the "heads I win, tails I don't lose much" asymmetry from three months ago (when the stock was $350) is gone, and the immediate resistance at $468 is less than 1% away. Conviction: The setup is genuinely balanced, not lopsided — a pullback to the $420–430 zone would restore the math, but at today's price the expected value is only modestly positive, not the 2–3x I look for.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- All six voices agree the underlying business strengthened materially this quarter — Azure's acceleration to 43% (guided to 45%), the $627B backlog (+99% YoY), and management's proactive handling of the AI-capex bear case are treated as facts, not narrative.
- Nobody on the panel identifies a business-quality or structural risk severe enough to warrant a SELL; every cautious voice explicitly wants to own Microsoft, just not chase the current price.
- The balance sheet is universally read as fortress-grade — low leverage, 50x interest coverage, no financial-distress risk under any scenario discussed.
- Every voice references the same technical fact even when it doesn't drive their signal: the stock is pressing directly against its nearest monthly resistance after a 21% one-week move, with the "easy money" from the $350 low already made.
The real debate
- The Scuttlebutt Growth Investor and The GARP Operator treat the 21% rally as irrelevant noise on top of a confirmed fundamental re-rating, while The Asymmetric Bargainer sees that same rally as having consumed the entire margin of safety that made the setup attractive three months ago.
- The Intrinsic-Value Modeler's DCF puts base and bear cases just $68 apart ($483 vs. $415) — a genuinely tight range that hinges entirely on whether AI capex reinvestment stays efficient, while The Moat Compounder treats the same capex as an already-proven, moat-widening investment rather than an open question.
- The Disruptive-Innovation Seeker frames Copilot's sub-5% penetration as enormous embedded optionality the market hasn't priced, while The Asymmetric Bargainer counts that same optionality as already reflected in a stock that just re-rated 21% in a week.
The question it comes down to: Does Microsoft's July 31 earnings beat mark the start of a confirmed breakout — a weekly close above USD 490 that resolves the monthly-vs-weekly momentum conflict — or has the 22% rally already spent the margin of safety, leaving the USD 427–435 zone as the only place left to add without paying for news that's already public?
The numbers
| Metric | Value |
|---|---|
| Price / Market cap | USD 464.72 / ~USD 3.0T |
| P/E (TTM / fwd) | 25.89x / 23.71x |
| ROE | 34.04% |
| Net margin | 40.31% |
| Dividend yield | 0.78% |
| Debt / equity | 0.29x |
| Free cash flow | USD 66.99B (TTM) |
Figures as of 2026-08-02; price as of the 2026-07-31 close ($464.72); sourced from stockanalysis.com.
The bottom line
The panel's business-quality verdict is no longer in question — five of six archetypes now call Microsoft an outright buy on fundamentals, up from one of six two weeks ago, on the strength of an earnings print that answered the AI-capex-conversion question the market had been waiting on. What keeps this WAIT rather than BUY is purely a price-and-timing objection: the stock is pressing against its nearest monthly resistance ($468.35) one week after a 22% rally, with the monthly MACD still bearish even as weekly momentum turns up. A confirmed weekly close above USD 490 would resolve that conflict and validate the breakout; a pullback into the USD 427–435 zone — where the deep-value and DCF-based voices both find their margin of safety — would be the cleaner entry. On the downside, two consecutive quarters of sub-30% Azure growth or a sequential decline in the $627B backlog would be the first sign the earnings beat was a peak, not a new base, and would override the price argument entirely.
contact@verdixhq.com · Published 2026-08-02 · Prices as of 2026-08-02 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Technology / Software & Cloud · 2026-08-08 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Microsoft's Q4 FY2026 earnings silenced fears that AI spending would destroy returns, but with the stock now perched at $500 (just beneath $505 Fibonacci resistance on thinning volume), our panel splits between those who see a 17% discount to intrinsic value worth seizing and those who see extreme bullish consensus as a reason to wait for either a confirmed breakout or a pullback to the $420s. The business is not in question; only the entry price and timing are.Level to watch
Key resistance 505.45+1.1% from 499.99
Next catalyst
Breakout confirmation level: A weekly close above $505.45 on volume at least 20% above the 20-week average would confirm the recovery and likely trigger multiple expansion toward analyst consensus targets in the $555–$650 range.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 499.99
What changed since 2026-08-02:
- Price: 464.72 → 499.99 (+7.59%)
- Panel: 5 of 6 → 5 of 6 now Bullish — composition also changed: added The Forensic Skeptic, The Macro Opportunist; removed The Asymmetric Bargainer, The Disruptive-Innovation Seeker
- Trigger: A weekly close above $505.45 on expanding volume confirms the breakout and flips verdict to BUY. A weekly close below $427.19 (weekly POC / Fib 61.8%) breaks the recovery structure and flips to SELL.
- Verdict: WAIT (unchanged)
Since the prior article on August 2, 2026 (price $464.72), Microsoft surged 7.6% on a decisive Q4 FY2026 earnings beat that fundamentally reset the narrative: Azure growth accelerated to 40%+ constant currency, management explicitly guided for positive free cash flow in FY27, and 30M paid Copilot seats confirmed AI monetization is scaling. Two new panel voices, The Forensic Skeptic and The Macro Opportunist, introduced fresh scrutiny around free cash flow quality and technical resistance at $505. Combined with the stock now sitting directly beneath that level on thinning volume, that scrutiny kept the verdict at WAIT despite the fundamentally improved business story.
The split is BUY vs WAIT, not BUY vs SELL: all seven bullish voices plus both cautious voices agree Microsoft is a wonderful business, but the two dissenting voices (technical-scout and The Forensic Skeptic) flag that $500 sits beneath the $505.45 weekly Fib resistance into thinning volume, with a bearish monthly MACD, extreme bullish consensus, and deteriorating FCF quality. The structure rule for BUY vs WAIT splits routes to WAIT: the business is not in question, only the entry price and timing.
Key levels
Key levels · MSFT
USD · as of 2026-08-08Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Microsoft Corporation past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: The moat is wide and getting wider: the combination of Azure, M365, and Copilot creates a sticky ecosystem that competitors will find very hard to replicate, and at 27.85x trailing earnings, the stock trades at a discount to its 5-year average of 32x. Conviction: Valuation caps the enthusiasm: at 27.85x trailing earnings this is merely a fair price for a wonderful business, and the FCF-to-net-income ratio of 0.70 signals some earnings quality slippage that warrants monitoring.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: With a PEG of 1.58, a fortress balance sheet, and management's explicit promise of positive free cash flow in FY27, this stalwart is fairly priced for a 14% grower with accelerating Azure momentum. Conviction: The monthly MACD is still flashing caution, so a weekly close above $505.45 on expanding volume is needed to confirm the breakout and remove the timing risk.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: My base-case DCF yields $585, roughly 17% upside from $500, driven by 15% revenue CAGR, 42% target operating margins, and the Q4 earnings decisively shifting the narrative from capex fear to AI monetization reality. Conviction: Multiple independent value drivers align here: accelerating Azure growth at 40%, management's FY27 positive-FCF guidance, and a technical recovery structure that supports the fundamental case.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: This is a rare 15-of-15 score on the scuttlebutt checklist: extraordinary management, a widening moat evidenced by 30M paid Copilot seats and 50M GitHub Copilot users, and secular AI tailwinds that justify holding almost never selling. Conviction: Every single qualitative criterion, from R&D effectiveness to management candor, independently confirms the thesis at exceptionally high conviction, and the recent 19% YTD decline offers a valuation rarely available for a compounder of this caliber.
The Forensic SkepticContrarian/Forensic🔴 BearishMed
Signal: The market is pricing in perfection with 93% analyst Buy ratings and a put/call ratio of 0.39, while free cash flow actually declined 23%. The depreciation policy change extending asset lives inflates reported earnings without generating a dollar of real cash. Conviction: Microsoft is undeniably a quality business, so the bearish call is entirely about price and consensus. A 10–15% pullback to the $400–$420 range would flip the signal, making this a timing bet rather than a structural short.
The Macro OpportunistMacro/Timing🟢 BullishMed
Signal: The Q4 earnings narrative reset is powerful: Azure accelerating to 45% constant-currency guidance and 30M paid Copilot seats confirm AI monetization is real, not vaporware. But the rally from $349 to $500 has occurred on thinning volume directly into $505 resistance. Conviction: The technical setup is the gate here: the weekly MACD crossover is promising but the monthly remains negative, and without a confirmed breakout above $505 on expanding volume, the reward for chasing at $500 doesn't justify the size.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Microsoft's business quality and competitive moat are not in dispute: all six voices agree the enterprise ecosystem (Azure, M365, Copilot) is deeply entrenched and widening.
- The Q4 FY2026 earnings beat was a genuine positive catalyst, with management's explicit guidance for positive FCF in FY27 directly addressing the market's primary concern about AI capex destruction.
- Valuation at 27.85x trailing / 25.4x forward is not expensive by Microsoft's historical standards (5-year average ~32x), regardless of whether each archetype views it as sufficient margin of safety.
- Azure growth acceleration to 40%+ constant currency and 30M paid Copilot seats represent real, measurable AI monetization, not mere narrative.
- The $505.45 weekly Fibonacci level is universally recognized as the technical threshold that separates recovery from confirmed breakout.
The real debate
- The Forensic Skeptic sees the 23% FCF decline and depreciation policy change as warning signs of deteriorating earnings quality masked by financial engineering, while The Scuttlebutt Growth Investor views the same accounting change as prudent and scores management integrity a perfect 15/15.
- The Macro Opportunist and The Forensic Skeptic both flag thinning volume above $500 and extreme bullish consensus (93% Buy ratings, 0.39 put/call) as contrarian caution signals, while The Intrinsic-Value Modeler and The Moat Compounder see the post-correction sentiment as recovering from a depressed base, not euphoric.
- The Moat Compounder would prefer waiting for a pullback to the $420–$440 zone for a proper margin of safety, while The Intrinsic-Value Modeler argues that at $500 the market is already offering a 17% discount to intrinsic value and waiting risks missing the entry entirely.
The question it comes down to: Does the Q4 FY2026 earnings-driven narrative shift from "AI capex will destroy returns" to "AI monetization is accelerating" justify buying Microsoft at $500 beneath unconfirmed technical resistance, or does the combination of deteriorating free cash flow quality, thinning volume, and extreme bullish consensus warrant patience for either a confirmed breakout above $505 or a pullback to the $420–$440 accumulation zone?
The bottom line
- Breakout confirmation level: A weekly close above $505.45 on volume at least 20% above the 20-week average would confirm the recovery and likely trigger multiple expansion toward analyst consensus targets in the $555–$650 range.
- Key support to hold: A weekly close below $427.19 (the volume-weighted POC and 61.8% Fibonacci retracement) would break the recovery structure and open a retest of the $392 weekly SMA 200, invalidating the bull case.
- Next catalyst: F1Q FY2027 earnings in October 2026 will test whether Azure's 45% constant-currency growth guidance and the FY27 positive-FCF promise hold; any deviation from either would rapidly unwind the post-Q4 optimism.
- Risk to monitor: Free cash flow quality remains the central unresolved tension. The FY27 positive-FCF guidance is based on assumptions about capex peaking, and another quarter of declining FCF would validate The Forensic Skeptic's concern that the depreciation policy change is masking cash-generation weakness.
contact@verdixhq.com · Published 2026-08-08 · Prices as of 2026-08-08 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
Why the panel isn’t ready to call MSFT yet — and where they disagree.
A quality business, but not at today's price — the panel is waiting for a better price or a catalyst.
NASDAQ · Technology / Software & Cloud · 2026-08-15 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
WaitMEDIUM confidence
Why
Five archetypes on the MSFT panel see a wide-moat AI compounder worth owning at or near $495, but the lone cautious voice refuses to pay up for capital-intensive growth, leaving the verdict stuck at WAIT: the business case is unassailable, yet the price has not pulled back far enough to satisfy disciplined buyers or broken out high enough to override the entry objection. The real debate is whether Microsoft's $80B annual AI capex will earn above its cost of capital — and the next earnings will provide the first tangible answer.Level to watch
Key resistance 505.45+2.0% from 495.4
Next catalyst
Trigger to confirm the breakout: A weekly close above $505.45 would signal the bull flag has resolved upward and shift the technical balance of upside to downside enough to override the pure price objection, potentially activating every voice on the panel.The panel's take
Verdict: WAIT · Conviction: MED · Last price: 495.4
What changed since 2026-08-08:
- Price: 499.99 → 495.4 (-0.92%)
- Panel: 5 of 6 → 4 of 5 now Bullish — composition also changed: added none; removed The Macro Opportunist
- Trigger: A pullback into the $425–$440 zone (weekly POC to monthly EMA20), which would widen the margin of safety toward The Intrinsic-Value Modeler's ($450) and The Forensic Skeptic's ($400) preferred level and activate every cautious voice. Alternatively, a weekly close above $505.45 (weekly 23.6% Fib) would confirm the bull-flag breakout and shift the technical balance of upside to downside sufficiently to override the price objection.
- Verdict: WAIT (unchanged)
The prior article reached the same WAIT verdict at $499.99, but the panel has since lost The Macro Opportunist (whose top-down lens added a cyclical caution that is now absent). The remaining five voices have not moved closer to consensus: The Moat Compounder, The GARP Operator, The Intrinsic-Value Modeler, and The Scuttlebutt Growth Investor remain bullish on the business, while The Forensic Skeptic remains sidelined purely on price. The price has barely moved (down 0.9%), so the verdict is unchanged not because anything broke in the story but because nothing in the price has yet resolved the tension — the stock remains stuck in the gap between the cautious entry zone ($400-450) and the breakout confirmation above $505.
Six of seven voices are unequivocally bullish on the business, and the lone dissenter (The Forensic Skeptic) explicitly praises Microsoft as "a great company" — his objection is purely that $500 is the wrong entry price. This is a classic BUY vs. PRICE/TIMING split: the business case is unassailable, but the disciplined buyer needs a lower entry. Per Step B, when the only objection is price/timing, the verdict synthesizes to WAIT — not BALANCED — because there is no genuine business-level disagreement to resolve.
Key levels
Key levels · MSFT
USD · as of 2026-08-15Key support & resistance — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
What legendary investors think
We ran Microsoft Corporation past a panel of 5 legendary investors' frameworks.
The panel · 5 investors
The Moat CompounderValue/Quality/Moat🟢 BullishHigh
Signal: At $495, you are buying a business with 40% net margins and a balance sheet carrying $37 billion in net cash that generates free cash flow even while funding a 110% capex increase, and Morningstar's $600 fair value estimate leaves a 17% margin of safety from current levels — exactly the profile of a wonderful business at a reasonable price. Conviction: Conviction strengthens because the quality signals are independently verifiable across multiple dimensions: the switching costs embedded in Office and Azure, the ROE of 34%, and the accelerating Copilot adoption (20M to 30M paid subscribers in three months) all confirm the moat is widening, not narrowing.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: The PEG ratio sits at 0.67 on trailing earnings when you measure against the latest quarter's 17% revenue growth, and Azure's 43% constant-currency growth paired with Copilot jumping from 20M to 30M subscribers in a single quarter means the story is not just intact but accelerating, making the forward P/E of 21-25x look undemanding for a company with a 45% operating margin. Conviction: Conviction gets a boost from the rare convergence of all three signals I watch: the story (Copilot and Azure adoption), the numbers (PEG below 1 and a pristine balance sheet), and the chart (bull flag resolving upward) are all pointing the same direction for the first time in months.
The Intrinsic-Value ModelerValuation/DCF🟢 BullishMed
Signal: My DCF produces a fair value of $570, roughly 15% above the current price, and the base-case assumptions embed a realistic glide path of 15% revenue growth decelerating to 4% over a decade rather than the heroic 18-20% growth the market narrative seems to discount, so the margin of safety is modest but genuine. Conviction: Conviction is anchored by the visibility of the revenue stream: Office 365 and Azure retention rates above 90% make the terminal value (65% of my total equity value) less speculative than it would be for most growth stories, though the single biggest variable — whether $80B in annual AI capex earns more than the 9.5% cost of capital — remains unresolved.
The Scuttlebutt Growth InvestorGrowth/Management🟢 BullishHigh
Signal: This is one of the rare companies that passes all 15 points of my checklist, and the 50% sequential jump in Copilot subscribers (from 20M to 30M) in just three months represents a real-world adoption curve, not financial engineering, confirming that the AI monetization engine is hitting product-market fit faster than even the optimists expected. Conviction: Conviction is held back only by the absence of a full cycle's worth of data on whether the $60B+ annual capex program will generate durable returns, but management's track record — Nadella and Hood have already monetized Office cloud, Azure, and Teams over the past decade — earns them the benefit of the doubt on this front.
The Forensic SkepticContrarian/Forensic⚫ NeutralLow
Signal: The short float sits at 1.1% and the put-call ratio at 0.25 while 93% of analysts rate this a Buy, and my sum-of-parts valuation (Azure at 30x, Office at 25x, Gaming at 15x) only reaches $450 — meaning the stock at $495 is already pricing in perfection with no room for the capex cycle to disappoint. Conviction: Conviction in the neutral call is tempered by the fact that I am not actively betting against this trend: the crowd could stay on one side of the boat longer than any fundamental short thesis can survive, so while the margin of safety is negative at current prices, the absence of a clear catalyst for reversion keeps me on the sidelines rather than taking a position.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Microsoft's business quality is exceptional: every archetype, including the lone cautious voice, agrees the company has a wide moat built on switching costs, a pristine balance sheet with $37B in net cash, and management that has earned credibility through consistent execution.
- The AI monetization story is real, not vapor: Copilot's growth from 20M to 30M paid subscribers and Azure's 43% constant-currency growth are independently verified adoption metrics that validate the demand thesis across frameworks.
- Valuation at $495 is not a bargain: even the most bullish voices concede the stock trades at fair value or a modest discount, and no one argues it is statistically cheap — the debate is whether fair value for this quality is good enough.
The real debate
- The Forensic Skeptic prices the AI capex as a liability until proven otherwise (negative margin of safety, intrinsic value around $380-400), while The Scuttlebutt Growth Investor and The Moat Compounder treat the capex as a moat-widening investment that management has earned the right to make, given their track record of monetizing cloud infrastructure.
- The Intrinsic-Value Modeler splits the difference mathematically: his DCF assumes the capex earns exactly the cost of capital (9.5%), producing a $570 fair value that leaves a 15% upside — a narrow but real margin that reflects neither the euphoria of The Scuttlebutt Growth Investor nor the deep skepticism of The Forensic Skeptic.
- The GARP Operator sees a PEG of 0.67 as evidence the market has not priced in near-term growth, while The Forensic Skeptic sees the same 27x trailing P/E on capital-intensive growth as a sign that marginal returns on the $80B capex program will disappoint — the same multiple, opposite conclusions.
The question it comes down to: Is the market overpaying for AI capex that may not earn its cost of capital, or is the moat wide enough that Microsoft can sustain premium growth and margins long enough to justify $495 — and if the answer depends on a pullback to $425-440, will the price offer that entry before the next earnings catalyst closes the window?
The bottom line
- Trigger to confirm the breakout: A weekly close above $505.45 would signal the bull flag has resolved upward and shift the technical balance of upside to downside enough to override the pure price objection, potentially activating every voice on the panel.
- Pullback zone to watch: A move into $425-440 would widen the margin of safety toward The Intrinsic-Value Modeler's preferred $450 entry and The Forensic Skeptic's $400 zone, converting the current WAIT into a coordinated buy signal across all frameworks.
- Next catalyst: Q1 FY2027 earnings (late October 2026) will be the first real test of whether the 110% capex increase is producing accelerating returns or merely sustaining Azure's growth rate as the base expands; a miss on Azure growth below 35% constant currency would break the bull case.
- Risk to monitor: If capex guidance increases another 20% or more on the next call without a commensurate acceleration in Azure AI revenue, The Forensic Skeptic's bear case (intrinsic value $380-400) gains probability and the margin-of-safety argument flips from cautious to actively bearish.
contact@verdixhq.com · Published 2026-08-15 · Prices as of 2026-08-15 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel’s case for MSFT — and where they disagree.
The case for outweighs the case against at today's price.
NASDAQ · Technology / Software & Cloud · 2026-08-22 · analysis, not advice
Key levels and fundamentals figures are sourced from public market data and filings. All panel verdicts, archetype reasoning, and synthesis are AI-generated analysis.
Verdict
BuyLOW confidence
Why
Microsoft's AI acceleration — Azure at 43% growth, Copilot subs doubling, a 12.6% earnings beat — draws four bullish votes against one bear and one neutral, but the panel's conviction stays low because the monthly chart warns of a momentum rollover and the stock sits just 3.5% above the intrinsic-value modeler's base case. The real debate is whether $116 billion in annual capex builds a wider moat or sets up a margin-compression trap that the crowd, at 93% buy ratings, is ignoring.Level to watch
Key resistance 489.7+1.3% from 483.24
Next catalyst
Line in the sand: A weekly close below $427.33 would break the Stage 2 uptrend by piercing both the 61.8% Fibonacci retracement and the volume POC cluster, flipping every bullish framework on this panel.The panel's take
Verdict: BUY · Conviction: LOW · Last price: 483.24 · Changed from WAIT
Panel: 4 Bullish · 1 Neutral · 1 Bearish → BUY
What changed since 2026-08-15:
- Price: 495.4 → 483.24 (-2.45%)
- Panel: 4 of 5 → 4 of 6 now Bullish — composition also changed: added The Activist Catalyst, The Quality Rationalist; removed The Scuttlebutt Growth Investor
- Trigger: A weekly close below $427.33 (the weekly 61.8% Fibonacci retracement and the volume POC cluster) would break the Stage 2 uptrend and flip every bullish voice. Alternatively, a weekly close above $505.45 (the weekly 23.6% Fib) would confirm the bull-flag breakout and resolve the monthly/weekly MACD tension bullishly.
- Verdict: WAIT → BUY
Last month the panel sat at WAIT because the bull case depended on a pullback to $425–$440 or a technical breakout above $505.45 — neither fired. Since then, price eased from $495.40 to $483.24 and the earnings story strengthened sharply (Azure at 43%, Copilot subs doubling, a 12.6% beat), pulling two cautious analysts off the sidelines into BUY. The single Neutral vote today is a pure valuation call, not a business-quality objection, which is why the panel tilts BUY despite conviction staying low.
The panel tips BUY (4-1-1) because the fundamental story accelerated sharply — Azure at 43% growth, Copilot subs doubling, a 12.6% earnings beat, and a forward P/E of 20.5x — while the prior WAIT trigger ($425–$440 pullback or $505.45 weekly close) was NOT FIRED: price traded from $495.40 to $483.24, dipping into but not reaching the pullback zone and never closing above $505.45. The two bullish analysts who were WAIT last time (The Moat Compounder and The GARP Operator) both now say BUY at the lower price with the stronger earnings evidence; only The Intrinsic-Value Modeler stays Neutral on valuation (intrinsic value ~$500, just 3.5% upside) and The Forensic Skeptic remains Bearish on crowded consensus and unsustainable capex. The single cautious voice objecting on PRICE/TIMING (The Intrinsic-Value Modeler) is offset by the four bulls who see enough value at $483 to act.
Key levels
Key levels · MSFT
USD · as of 2026-08-22Analyst consensus target 576.93 USD · range 404–913.5
Key support & resistance and analyst consensus — educational analysis, not advice. These are not entry or exit prices. Trading involves risk of loss.
Key support sits at $475.59 (the weekly 38.2% Fibonacci retracement, the nearest structural floor just 1.6% below price), backed by the $451.46 weekly 50% Fib. The $427–$434 cluster is the critical battleground: the weekly 61.8% Fib at $427.33, the highest-volume weekly node (POC) at $427.19, the weekly EMA50 at $434.13, and the EMA20 at $430.76 all converge there — a break of this zone would end the weekly uptrend. Key resistance begins at $489.70 (weekly horizontal, tested and rejected on the decline from the ATH), then the $505.45 weekly 23.6% Fib — a close above that level confirms the bull-flag breakout — with the ATH cluster at $553.72–$555.45 as the ultimate ceiling. The analyst consensus target of $576.93 offers 19.4% upside from the AS-OF price.
What legendary investors think
We ran Microsoft Corporation past a panel of 6 legendary investors' frameworks.
The panel · 6 investors
The Moat CompounderValue/Quality/Moat🟢 BullishMed
Signal: Azure's remaining performance obligations swelled to $678 billion (up 84%) and Copilot paid subscribers jumped from 20 million to 30 million in a single quarter, confirming that Microsoft's switching-cost moat is widening, not narrowing. Conviction: Conviction is tempered by the monthly MACD bearish crossover, which warns that price may revisit the $427–$434 accumulation zone before the uptrend resumes.
The GARP OperatorGrowth (GARP)🟢 BullishMed
Signal: Forward P/E of 20.5x against 19% EPS growth produces a PEG of 1.12, placing a business with 47% operating margins and $67 billion in free cash flow squarely in buy territory under the GARP Operator framework. Conviction: The one soft spot holding conviction back is the unresolved monthly MACD bearish cross: weekly momentum is improving, but the longer-timeframe signal has not yet flipped.
The Intrinsic-Value ModelerValuation/DCF⚫ NeutralMed
Signal: The base-case DCF lands at $500, only 3.5% above the current price, because heavy capex at 35% of revenue depresses near-term free cash flow even as 15% revenue growth reflects genuine AI tailwinds. Conviction: Conviction stays neutral because the narrow margin of safety leaves no cushion if AI monetization decelerates faster than the market expects.
The Quality RationalistMental Models/Quality🟢 BullishMed
Signal: Operating margins near 47% and ROE above 30% persist even as the business pours 35% of revenue into AI infrastructure, proving the competitive dynamic is extraordinary rather than fragile. Conviction: Conviction is held back because the 93% analyst buy rating and near-zero short interest signal a crowded consensus, and the monthly MACD divergence adds a timing concern.
The Forensic SkepticContrarian/Forensic🔴 BearishLow
Signal: With 93% of analysts rating it Buy, short interest at just 1.1%, and call/put ratios levered 4-to-1 long, the stock is a textbook crowded glamour trade where the exit door narrows before trouble becomes visible. Conviction: Conviction on the bear side firms up because normalized P/E and conservative DCF models point to a value closer to $400–$420, implying 13–17% downside with no tangible book value to catch the fall.
The Activist CatalystActivist/Capital Allocation🟢 BullishHigh
Signal: Pershing Square disclosed a new $2.09 billion stake (5.7 million shares) in Q2 2026, and EV/EBITDA at 18.2x sits well below its five-year average of 23x, signaling a compressed entry multiple on a business with $678 billion in contracted future revenue. Conviction: Conviction runs high because the AI monetization catalysts are already visible in the numbers — Azure at 43% growth, Copilot subs doubling — and the discounted valuation offers a clear path to mean reversion.
Each view is one investing framework applied to the stock — a perspective, not advice, and identical for every reader. Signals are the panel's own scale, not a recommendation to act.
Where they agree — and where they clash
Common ground
- Microsoft's enterprise moat, anchored by Office 365 and Azure switching costs, is exceptionally durable and possibly widening through AI adoption.
- The financial foundation is outstanding: 34% ROE, 47% operating margins, conservative debt, and $67 billion in free cash flow.
- The $678 billion remaining performance obligation provides multi-year revenue visibility unmatched by most peers.
- A weekly close below the $427–$434 zone would be structurally damaging for the bullish case across virtually every framework.
- The monthly MACD bearish crossover introduces a timing tension that even the bulls acknowledge, even if they weight it differently.
The real debate
- The Intrinsic-Value Modeler sees a stock whose DCF value ($500) hugs the current price too tightly to justify a buy, while The Activist Catalyst views EV/EBITDA compression to 18.2x (versus a 23x historical average) as a genuine discount.
- The Forensic Skeptic warns that $116 billion in capex at 35% of revenue and a net reinvestment rate near 86% of net income represent an all-in bet on AI with zero margin for error, whereas The Quality Rationalist interprets that same capex as evidence of demand outpacing supply and a durable competitive advantage being built.
- The Moat Compounder and The GARP Operator both upgraded from WAIT to BUY on the price pullback and stronger earnings, but The Intrinsic-Value Modeler stayed Neutral because the fundamental valuation gap remains too narrow even after the decline.
The question it comes down to: Will AI monetization accelerate fast enough to absorb $116 billion in annual capex before the market's patience with margin compression runs out?
The bottom line
- Line in the sand: A weekly close below $427.33 would break the Stage 2 uptrend by piercing both the 61.8% Fibonacci retracement and the volume POC cluster, flipping every bullish framework on this panel.
- Breakout confirmation: A weekly close above $505.45 resolves the monthly/weekly MACD tension bullishly and confirms the flag pattern, which would remove the last timing objection held by the cautious voices.
- Next earnings catalyst: Azure growth decelerating below 30% or a guidance cut at the November 2026 report would break the narrative that the AI capex cycle is self-funding.
- Sentiment to monitor: A reduction in the 4:1 call/put ratio or a rise in short interest above 3% would indicate the crowded long trade is unwinding, the scenario Forensic Skeptic expects to precede a re-rating lower.
contact@verdixhq.com · Published 2026-08-22 · Prices as of 2026-08-22 · Time horizon: 3–12 months · No direct position held in MSFT · MSFT verdict history → · Methodology →
Verdix's panel is made up of AI archetypes that apply the well-documented, publicly known investment frameworks of famous investors. They are AI agents — not the investors themselves. Verdix is not affiliated with, endorsed by, or authorized by any real individual, and the archetypes do not represent any real person's actual views, holdings, or statements. Every verdict is AI-generated.
Verdix provides educational equity research and AI-generated multi-perspective analysis. Nothing here constitutes personalized investment advice or a recommendation to buy or sell any security. Verdicts are uniform across all users and do not consider your individual financial situation, risk tolerance, or objectives. Trading and investing involve substantial risk of loss. Past performance does not predict future results. Consult a licensed financial advisor before making investment decisions.
The panel also debated